News related to Cataflam (Diclofenac) and/or conditions it is approved for
Pharmos Announces Clinical Results From Phase 2a Trial Of Topical Diclofenac NanoEmulsion Cream
Source: Clinical Trials / Drug Trials News From Medical News Today [2008.11.20]
Pharmos Corporation (Nasdaq: PARS) announced results from its Phase 2a clinical trial of its topical NanoEmulsion (NE) drug delivery technology formulated with 3% Diclofenac Diethanolamine. The multi-center, randomized, double-blinded, placebo controlled study evaluated the safety and efficacy of the Company's 3% Diclofenac Diethanolamine NanoEmulsion cream in 104 patients with chronic pain due to osteoarthritis of the knee.
diclofenac and misoprostol, Arthrotec
Source: MedicineNet meloxicam Specialty [2005.12.13]
Title: diclofenac and misoprostol, Arthrotec
Category: Medications
Created: 11/22/1998 6:38:00 PM
Last Editorial Review: 12/13/2005
APR Applied Pharma Research And Fidia Farmaceutici Receive IND Approval From FDA For A New NSAID Matrix Patch Product
Source: Clinical Trials / Drug Trials News From Medical News Today [2008.11.19]
Applied Pharma Research sa (APR), and Fidia Farmaceutici SpA (Fidia) today announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for the development of a 140mg Diclofenac Sodium Matrix Patch for the topical treatment of acute pain due to minor strains, sprains and contusions.
|
